Purpose | Board Meetings Date | Announcement Date |
---|---|---|
Board Meeting | 13 Nov 2024 | 8 Nov 2024 |
Adeshwar Meditex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve To consider and approve the Standalone Un-Audited Financial Result of the Company along with Limited Review Report (LRR) for the half year ended September 30 2024; Any other matter with the permission of the Chair. Outcome of Board meeting held on Wednesday, November 13, 2024 for approval of Unaudited Financial Results for half year ended September 30, 2024 (As Per BSE Announcement dated on 13.11.2024) | ||
Board Meeting | 26 Aug 2024 | 22 Aug 2024 |
Adeshwar Meditex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/08/2024 inter alia to consider and approve change in designation of Dr. Krishnojirao Nagaraja Rao from whole-time director to Whole-time director and Chairperson of the company. change in designation of Mrs. Ashalata Raut from Whole-time director to Managing Director of the company. take note of resignation of Mr. Nagaraja Rao Abhinandan from the position of Chief Financial Officer (CFO). appointment of Mr. Prashant Rane as Chief Financial Officer (CFO) of the company. appointment of Mr.Nagaraja Rao Abhinandan as Additional Executive Director of the company. appointment of Dr. Prithvi Singh as Additional Non-Executive Director of the company. appointment of director retiring by rotation. approve the Directors Report of the company along with all annexure thereof for F.Y. 2023-24. the notice convening 17th Annual General Meeting of the Company. finalize the appointment of Mr. Deep Shukla Practising Company Secretary as the scrutinizer to oversee the voting process in a fair and transparent manner. Change in designation of Dr. Krishnojirao Nagaraja Rao from whole-time director to Whole-time director and Chairperson of the company Change in designation of Mrs. Ashalata Raut from Whole-time director to Managing Director of the company Resignation of Mr. Nagaraja Rao Abhinandan from the position of Chief Financial Officer (CFO) Appointment of Mr. Prashant Rane as Chief Financial Officer (CFO) of the company Appointment of Mr. Nagaraja Rao Abhinandan as Additional Executive Director of the company Appointment of Dr. Prithvi Singh as Additional Non-Executive Director of the company Appointment of director retiring by rotation. The Directors Report of the company along with all annexure thereof for F.Y. 2023-24. Approval of Notice of Annual General Meeting to be held on Wednesday, September 25, 2024 at 02:30 PM at the registered office of the Company The appointment of Mr. Deep Shukla, Practicing Company Secretary as the scrutinizer (As per BSE Announcement Dated on 26/08/2024) | ||
Board Meeting | 22 May 2024 | 15 May 2024 |
Adeshwar Meditex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2024 inter alia to consider and approve The Standalone Audited Financial Results of the Company for the quarter and financial year ended 31st March 2024; Appointment of Company Secretary & Compliance officer. Any other matter with the permission of the Chair. With reference to the above captioned subject, we wish to intimate your esteemed exchange that as decided in the Meeting of the Board of Directors of the Company held today, i.e. on May 22, 2024, for which intimation was already given to you, the Board of Directors has: 1. Considered and approved appointment of Mr. Vishal Jain as the Company Secretary of the Company and fixing of the remuneration; 2. Consider and approved the Standalone Audited Financial Statements and Results of the Company along with auditors report for the half year and financial year ended 31st March, 2024. In connection with Point No. 2, please find enclosed the copy of Audited Standalone financial Results of the Company for the half year and financial year ended 31st March, 2024 along with auditors report of the Company as Annexure-I. (As per BSE Announcement Dated on 22/05/2024) |
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.